June 20, 2016
The Ministry of Health, Labor and Welfare (MHLW) granted approval to Japan Tobacco’s anti-HIV drug Genvoya (elvitegravir + cobicistat + emtricitabine + tenofovir alafenamide (TAF)) on June 17. The new agent encapsulates three of the same active ingredients as the...read more